Join our daily newsletter At The Bell to receive exclusive market insights
- eHealth company Respiri (RSH) has entered two consecutive trading halts as it plans a capital raise
- At this stage, it is uncertain how much the company is aiming to raise and where the money will go
- Respiri shares will remain paused until Tuesday, October 20, or when the company releases more details about the raise
- Company shares last traded for 23.5 cents each on October 13
eHealth company Respiri (RSH) has entered two consecutive trading halts as it plans a capital raise.
At this stage, it is uncertain how much the company is aiming to raise and where the money will go.
For now, Respiri shares will remain paused until Tuesday, October 20, or when the company releases more details about the raise.
Last month, Respiri appointed Entech Electronics as its global partner to supply its wheezo device.
The company’s wheezo technology monitors wheezing to help manage and improve asthma symptoms.
The Entech partnership will allow the company to increase unit production and meet its forecasted global demand.
Respiri has now placed its first orders for the wheezo device, while Entech is preparing for production at its facility in Shenzhen, China.
Company shares last traded for 23.5 cents each on October 13.
